{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:21:52Z","timestamp":1787772112522,"version":"build-2784847793"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>Malignant pleural effusion (MPE) occurs in approximately 15% of cancer patients and is associated with poor prognosis, with a median survival of 3\u201312 months. Expected survival is a key factor in treatment decision-making. This study aimed to identify clinical and laboratory parameters affecting survival in patients with MPE and to evaluate the prognostic performance of the LENT, PROMISE, AL, and Eastern Cooperative Oncology Group Performance Status (ECOG-PS) scores in predicting mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>This retrospective study included 161 patients pathologically diagnosed with MPE at a tertiary care center between January 2010 and December 2024. Overall survival was defined as the time from MPE diagnosis to death. LENT, PROMISE, AL, and ECOG-PS scores were calculated at diagnosis. Three-month mortality was the primary endpoint.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      The median overall survival was 93 days, and the 3-month survival rate was 50.1%. Univariate analysis showed that body mass index \u226525 kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      , gastrointestinal tract malignancies, presence of extrapleural metastases, elevated leukocyte, neutrophil, and platelet counts, an increased neutrophil-to-lymphocyte ratio, and higher pleural fluid lactate dehydrogenase levels were significantly associated with mortality. ECOG-PS, LENT, and PROMISE scores were significant predictors of both 3-month and overall mortality. In multivariate analysis, ECOG-PS was the strongest independent predictor of 3-month mortality (hazard ratio [HR]: 46.63; 95% confidence interval [CI]: 14.23\u2013152.83), followed by LENT (HR: 4.66; 95% CI: 2.77\u20137.85) and PROMISE (HR: 2.39; 95% CI: 1.41\u20134.03). ECOG-PS also remained the strongest predictor of overall mortality.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>ECOG-PS, together with LENT and PROMISE scores, are effective and clinically applicable tools for predicting early and overall mortality in patients with MPE.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/atm.atm_2_26","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T15:00:33Z","timestamp":1781708433000},"page":"162-171","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of prognostic scores and factors affecting survival in patients with malignant pleural effusion"],"prefix":"10.4103","volume":"21","author":[{"given":"S\u00fcmeyye Kodalak","family":"Cengiz","sequence":"first","affiliation":[{"name":"Department of Pulmonary Diseases, Faculty of Medicine, Gazi University, Yenimahalle, Ankara, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nevin Taci","family":"Hoca","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Diseases, Faculty of Medicine, Gazi University, Yenimahalle, Ankara, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00fclya","family":"Kaya","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Diseases, Faculty of Medicine, Gazi University, Yenimahalle, Ankara, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onur","family":"Ertun\u00e7","sequence":"additional","affiliation":[{"name":"Department of Pathology, Faculty of Medicine, Gazi University, Yenimahalle, Ankara, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cansu","family":"\u00d6zbas","sequence":"additional","affiliation":[{"name":"Department of Public Health, Faculty of Medicine, Gazi University, Yenimahalle, Ankara, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilg\u00fcn Y\u0131lmaz","family":"Demirci","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Diseases, Faculty of Medicine, Gazi University, Yenimahalle, Ankara, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet Selim","family":"Yurdakul","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Diseases, Faculty of Medicine, Gazi University, Yenimahalle, Ankara, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"key":"R1-20260706","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/ejcts\/ezy258","article-title":"ERS\/EACTS statement on the management of malignant pleural effusions","volume":"55","author":"Bibby","year":"2019","journal-title":"Eur J Cardiothorac Surg"},{"key":"R2-20260706","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1183\/16000617.0019-2016","article-title":"Malignant pleural effusion: From bench to bedside","volume":"25","author":"Psallidas","year":"2016","journal-title":"Eur Respir Rev"},{"key":"R3-20260706","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1513\/AnnalsATS.201902-189CME","article-title":"Contemporary approach to the diagnosis of malignant pleural effusion","volume":"16","author":"Kaul","year":"2019","journal-title":"Ann Am Thorac Soc"},{"key":"R4-20260706","doi-asserted-by":"crossref","first-page":"230145","DOI":"10.1183\/20734735.0145-2023","article-title":"Malignant pleural disease","volume":"19","author":"Piggott","year":"2023","journal-title":"Breathe (Sheff)"},{"key":"R5-20260706","doi-asserted-by":"crossref","first-page":"e076962","DOI":"10.1136\/bmj-2023-076962","article-title":"25 year trends in cancer incidence and mortality among adults aged 35-69 years in the UK, 1993\u20132018: Retrospective secondary analysis","volume":"384","author":"Shelton","year":"2024","journal-title":"BMJ"},{"issue":"Suppl 2","key":"R6-20260706","first-page":"ii32","article-title":"Management of a malignant pleural effusion: British Thoracic Society Pleural Disease Guideline 2010","volume":"65","author":"Roberts","year":"2010","journal-title":"Thora\u00d7"},{"issue":"1","key":"R7-20260706","doi-asserted-by":"crossref","first-page":"FSO958","DOI":"10.2144\/fsoa-2023-0168","article-title":"Validating LENT score in malignant pleural effusion","volume":"10","author":"Alawneh","year":"2024","journal-title":"Future Sc\u0130 OA"},{"key":"R8-20260706","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1136\/thoraxjnl-2014-205285","article-title":"Predicting survival in malignant pleural effusion: Development and validation of the LENT prognostic score","volume":"69","author":"Clive","year":"2014","journal-title":"Thora\u00d7"},{"key":"R9-20260706","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1007\/s13304-024-01985-2","article-title":"Comparison of five scores to predict mortality in malignant pleural effusion","volume":"76","author":"Ayik T\u00fcrk","year":"2024","journal-title":"Updates Surg"},{"key":"R10-20260706","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1183\/23120541.01019-2024","article-title":"External validation of the LENT and PROMISE prognostic scores for malignant pleural effusion","volume":"11","author":"Mounsey","year":"2025","journal-title":"ERJ Open Res"},{"key":"R11-20260706","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.chest.2021.03.059","article-title":"Breast and lung effusion survival score models: Improving survival prediction in patients with malignant pleural effusion and metastasis","volume":"160","author":"Molina","year":"2021","journal-title":"Chest"},{"key":"R12-20260706","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1111\/crj.13700","article-title":"Development and validation of the CAIL prognostic score in non-small cell lung cancer patients with malignant pleural effusion","volume":"17","author":"Li","year":"2023","journal-title":"Clin Respir J"},{"key":"R13-20260706","first-page":"1083524","article-title":"Impact of immunotherapy in lung cancer","volume":"12","author":"Ferreira","year":"2022","journal-title":"Front Media SA"},{"key":"R14-20260706","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1111\/resp.13837","article-title":"Malignant pleural effusion survival prognostication in an Asian population","volume":"25","author":"Quek","year":"2020","journal-title":"Respirology"},{"key":"R15-20260706","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S1470-2045(18)30294-8","article-title":"Development and validation of response markers to predict survival and pleurodesis success in patients with malignant pleural effusion (PROMISE): A multicohort analysis","volume":"19","author":"Psallidas","year":"2018","journal-title":"Lancet Oncol"},{"key":"R16-20260706","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/1759-7714.13262","article-title":"Prognostic value of a new score using serum alkaline phosphatase and pleural effusion lactate dehydrogenase for patients with malignant pleural effusion","volume":"11","author":"Shi","year":"2020","journal-title":"Thorac Cancer"},{"key":"R17-20260706","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1111\/cts.13260","article-title":"Prognostic impact of pleural effusion in patients with malignancy: A systematic review and meta-analysis","volume":"15","author":"Yang","year":"2022","journal-title":"Clin Transl Sci"},{"key":"R18-20260706","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12890-015-0025-z","article-title":"Important prognostic factors for survival in patients with malignant pleural effusion","volume":"15","author":"Zamboni","year":"2015","journal-title":"BMC Pulm Med"},{"key":"R19-20260706","first-page":"1423","article-title":"Performance status assessment among oncology patients: A review","volume":"70","author":"Orr","year":"1986","journal-title":"Cancer Treat Rep"},{"key":"R20-20260706","doi-asserted-by":"crossref","first-page":"e213520","DOI":"10.1001\/jamanetworkopen.2021.3520","article-title":"Association of obesity with survival outcomes in patients with cancer: A systematic review and meta-analysis","volume":"4","author":"Petrelli","year":"2021","journal-title":"JAMA Netw Open"},{"key":"R21-20260706","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1016\/j.ejca.2011.03.028","article-title":"A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow inflammation outcome study","volume":"47","author":"Proctor","year":"2011","journal-title":"Eur J Cancer"},{"key":"R22-20260706","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1245\/s10434-011-1814-0","article-title":"Usefulness of the neutrophil-to-lymphocyte ratio in predicting short- and long-term mortality in breast cancer patients","volume":"19","author":"Azab","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"R23-20260706","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/bjc.2012.292","article-title":"A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer","volume":"107","author":"Proctor","year":"2012","journal-title":"Br J Cancer"},{"key":"R24-20260706","doi-asserted-by":"crossref","first-page":"e0250628","DOI":"10.1371\/journal.pone.0250628","article-title":"Neutrophil-to-lymphocyte ratio in malignant pleural fluid: Prognostic significance","volume":"16","author":"Popowicz","year":"2021","journal-title":"PLoS One"},{"key":"R25-20260706","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1186\/s12885-017-3550-8","article-title":"Prognostic impact of a new score using neutrophil-to-lymphocyte ratios in the serum and malignant pleural effusion in lung cancer patients","volume":"17","author":"Lee","year":"2017","journal-title":"BMC Cancer"},{"key":"R26-20260706","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.critrevonc.2013.03.010","article-title":"The systemic inflammation-based neutrophil-lymphocyte ratio: Experience in patients with cancer","volume":"88","author":"Guthrie","year":"2013","journal-title":"Crit Rev Oncol Hematol"},{"key":"R27-20260706","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4103\/1687-8426.198999","article-title":"Value of C-reactive protein in differentiation between tuberculous and malignant pleural effusion","volume":"11","author":"Mohamed","year":"2017","journal-title":"Egypt J Bronchol"},{"key":"R28-20260706","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12935-022-02518-w","article-title":"Prognostic biomarkers of malignant patients with pleural effusion: A systematic review and meta-analysis","volume":"22","author":"Peng","year":"2022","journal-title":"Cancer Cell Int"},{"key":"R29-20260706","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1164\/rccm.201203-0465PP","article-title":"Malignant pleural effusion: Tumor-host interactions unleashed","volume":"186","author":"Stathopoulos","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"R30-20260706","doi-asserted-by":"crossref","first-page":"4721","DOI":"10.1038\/s41598-019-41289-9","article-title":"Elevated pretreatment platelet-to-lymphocyte ratio is associated with poor survival in stage IV non-small cell lung cancer with malignant pleural effusion","volume":"9","author":"Lim","year":"2019","journal-title":"Sci Rep"},{"key":"R31-20260706","doi-asserted-by":"crossref","first-page":"106650","DOI":"10.1016\/j.rmed.2021.106650","article-title":"Evaluation of prognostication scores and proposal for refinement in malignant pleural effusion in Asians","volume":"189","author":"Wong","year":"2021","journal-title":"Respir Med"},{"key":"R32-20260706","doi-asserted-by":"crossref","first-page":"133","DOI":"10.5578\/tt.20219802","article-title":"Can LENT prognostic score (LDH, ECOG performance score, blood neutrophil\/lymphocyte ratio, tumor type) change the clinical approach in malignant pleural effusion?","volume":"69","author":"Gayaf","year":"2021","journal-title":"Tuberk Toraks"},{"key":"R33-20260706","doi-asserted-by":"crossref","first-page":"341","DOI":"10.5578\/tt.20229605","article-title":"The clinical utility of the LENT score in patients with malignant pleural mesothelioma","volume":"70","author":"S\u00f6yler","year":"2022","journal-title":"Tuberk Toraks"},{"key":"R34-20260706","doi-asserted-by":"crossref","first-page":"325","DOI":"10.4103\/lungindia.lungindia_633_21","article-title":"The role of LENT and PROMISE scores in predicting survival in malignant pleural effusion","volume":"39","author":"Ermin","year":"2022","journal-title":"Lung India"},{"key":"R35-20260706","doi-asserted-by":"crossref","first-page":"107854","DOI":"10.1016\/j.rmed.2024.107854","article-title":"Prognostic role of pleural fluid SUVpeak value obtained from 18F-FDG PET\/CT in patients with malignant pleural effusion","volume":"236","author":"Atasever","year":"2025","journal-title":"Respir Med"}],"container-title":["Annals of Thoracic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/atm.atm_2_26","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:30:27Z","timestamp":1787769027000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/atm.atm_2_26"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/atm.atm_2_26","relation":{},"ISSN":["1817-1737","1998-3557"],"issn-type":[{"value":"1817-1737","type":"print"},{"value":"1998-3557","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]},"assertion":[{"value":"2026-01-02","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-30","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}